{"entity":{"id":"nct06617481","kind":"trial","name":"PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence","aka":[],"tldr":"A phase 2 trial of Flotufolastat F-18 in Prostate cancer, run by AdventHealth, now recruiting.","summary":"PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence is a phase 2 interventional study registered as NCT06617481 by AdventHealth, with 30 participants planned, started 2024-09-20 and due to reach its primary completion in 2027-09-05. Interventions recorded: 18F-rhPSMA-7.3 (Posluma). Conditions recorded: Prostate Cancer (Post Prostatectomy).\n\nLinked to the drug Flotufolastat F-18 because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.","status":"recruiting","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT06617481","url":"https://clinicaltrials.gov/study/NCT06617481"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["prostate"],"sections":[],"technologies":[],"targets":[],"drugs":["flotufolastat"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06617481","phase":"2","setting":"RhPSMA-7.3(18F)-PET Scan to Detect Prostate Cancer in Patients with Early PSA Recurrence","sponsor":"AdventHealth","enrolled":30,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06617481/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"drug":[{"id":"flotufolastat","kind":"drug","name":"Flotufolastat F-18","route":"/drugs/flotufolastat/"}]}}